- Gilead nabs deal with CV Therapeutics; Rituxan fails trial in ... - FiercePharma
- Merck Outlines Long-Term Prospects and Progress on Strategic Plan ... - MarketWatch
- Report: Pfizer eyeing Wockhardt divisions; Genzyme nabs EU nod for ... - FiercePharma
- In overseas push, FDA opens Costa Rica office; US flu strain ... - FiercePharma
- Path sought for generic biologic drugs - San Diego Union Tribune
FDA gives nod to generic Plan B; Takeda may lose replacement for ... - FiercePharma
FDA gives nod to generic Plan B; Takeda may lose replacement for ...FiercePharmaAnd the researcher in charge of a tiny clinical trial says he's confident that the breakthrough approach can either lead to a cure or long-term remission ...Takeda Hurt by Star Drug's Patent Loss, FDA DelayBloombergall 3 news articles »
